Post-Market Clinical Follow-Up of the CT3 Series Continuous Glucose Monitoring System: A 14-Day Observational Study Assessing Accuracy, Safety, and Glucose Control in Patients With Type 1 and Type 2 Diabetes Mellitus
This record was last updated August 22, 2025 (before its estimated September 17, 2025 completion). Its status may not reflect the trial's current state.
Summary
Post market Clinical follow-up of the CT3 Series Continuous Glucose Monitoring System: A 14-Day Observational Study Assessing Accuracy, Safety, and Glucose Control in patients with Type 1 and Type 2 Diabetes Mellitus
Protocol Amendment History
1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-13.